Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Farmers Insurance
Queensland Health
Accenture
AstraZeneca
Deloitte
Merck
Cipla
Federal Trade Commission

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,469,015

« Back to Dashboard

Which drugs does patent 6,469,015 protect, and when does it expire?

Patent 6,469,015 protects DENAVIR and is included in one NDA.

This patent has thirty-three patent family members in twenty-seven countries.
Summary for Patent: 6,469,015
Title: Pharmaceutical formulation
Abstract:An oil-in-water topical pharmaceutical formulation or an aqueous formulation for the treatment of virus infections of the skin or mucosa, comprising at least 30% of propylene glycol and solubilized penciclovir.
Inventor(s): Griffiths; Hazel-Ann (Dorking, GB), Goodall; Alan John (Worthing, GB), Oduro-Yeboah; Joshua (Worthing, GB)
Assignee: Novartis International Pharmaceutical Ltd (Hamilton, BM)
Application Number:08/462,257
Patent Claim Types:
see list of patent claims
Formulation; Use;

Drugs Protected by US Patent 6,469,015

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Mylan Pharms Inc DENAVIR penciclovir CREAM;TOPICAL 020629-001 Sep 24, 1996 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) IN ADULTS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,469,015

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 197 ➤ Try a Free Trial
African Regional IP Organization (ARIPO) 9000236 ➤ Try a Free Trial
Austria 142880 ➤ Try a Free Trial
Australia 643975 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Julphar
Harvard Business School
McKinsey
Argus Health
Boehringer Ingelheim
Queensland Health
Chinese Patent Office
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.